|

New Hope for Mesothelioma Patients in Intensive Care

ByHolly Zink
New Hope for Mesothelioma Patients in Intensive Care

In the fight against mesothelioma, there’s new and hopeful data that might help patients who end up in the intensive care unit (ICU). A recent study gives us important details about how some patients are getting better, and this is good news for people around the world.

ICU Success for Mesothelioma Patients

Mesothelioma is a rare kind of cancer caused by asbestos. It mostly affects the lining of the lungs and chest. This can lead to problems like trouble breathing, chest pain, coughing, and feeling tired a lot. But what happens when mesothelioma patients have a very serious health issue and need to go to the ICU?

We know that 5% of cancer patients have to go to the ICU within two years of finding out they have cancer. But we don’t know a lot about what happens after they come out of the ICU. Researchers wanted to learn more about what helps patients get better and survive one year after being in the ICU.

In this study, researchers looked at 253 cancer patients in the ICU, mostly those with lung cancer. The results were impressive: 37.2% of these patients were able to leave the ICU and go home within three months. And about 28.5% of them were still doing well after one year.

These results are really important. More than one-third of the patients who had to go to the ICU could go back home in just three months. The patients’ pre-existing health status, treatment, and severity of illness all played a part in their recovery. This news could make a big difference for very sick patients and their families, giving them new hope.

Positive Trends in Critical Care for Advanced Cancer

Doctors are trying hard to make treatments that work better for each patient. The study also shows how important it is for doctors to work together. This way, they can give the best care to mesothelioma patients who are in critical condition.

These findings are like a light that shows there’s hope for mesothelioma patients who end up in the ICU. With more research and new ideas, we’re moving toward a time when patients can have better care, a better life, and a better chance of getting well, especially when things are very serious.

Facing mesothelioma is tough, but this study gives us reasons to be hopeful. From the strength of patients to the work of doctors, there’s a path forward to better outcomes in the ICU. Researchers are on a promising path to better care, improved quality of life, and enhanced survival rates for those who need it the most.

Source

Gonzalez, F., Starka, R., Ducros, L., Bisbal, M., Chow-Chine, L., Servan, L., de Guibert, J.-M., Pastene, B., Faucher, M., Sannini, A., Leone, M., & Mokart, D. (2023). Critically ill metastatic cancer patients returning home after unplanned ICU stay: An observational, multicentre retrospective study. Annals of Intensive Care, 13(1), 73. https://doi.org/10.1186/s13613-023-01170-5

Similar Posts

  • |

    Mesothelioma Still Carries Heavy Mortality Burden in U.S.

    ByAlex Strauss

    Asbestos exposure cost Americans more than 427,000 years of potential life in the first decade of the new millennium. That figure comes from a study on mesothelioma and asbestosis – the two most deadly asbestos-related diseases – conducted by the CDC’s National Institute for Occupational Safety and Health (NIOSH). Using National Center for Health Statistics mortality data, NIOSH researchers evaluated premature deaths and “loss of potentially productive years of life” attributable to either asbestosis or mesothelioma between 1999 and 2010. The data included only people 25 years or older with an underlying cause of death listed on their death certificate of either asbestosis or malignant mesothelioma. When the figures were calculated using the normal life expectancy for each asbestosis victim…

  • |

    Mesothelioma Rates Expected to Rise for Another Decade

    ByAlex Strauss

    Most developed countries can expect another decade or more of rising mesothelioma rates before the incidence of the disease starts to wane. That is one of the major findings in a recent report from The Baird Institute for Applied Heart and Lung Surgical Research in Australia. The report, which looked at the causes, distribution and projected future incidence of malignant mesothelioma, contains both good and bad news for the U.S.. Mesothelioma is an aggressive and often fatal cancer caused by exposure to asbestos.  It is thought to be triggered by chronic inflammation and irritation in the lung tissue and the surrounding pleural membrane by the sharp asbestos fibers.   Mesothelioma often takes decades to develop. According to the Baird Institute report, the average…

  • |

    Peritoneal Mesothelioma Study: Long-Term Survival is Possible

    ByAlex Strauss

    A new study out of Italy has some encouraging news for patients with the peritoneal form of malignant mesothelioma. The recent analysis of 108 peritoneal mesothelioma patients who underwent complete cytoreductive surgery (CRS) followed by a rinse of heated chemotherapy (HIPEC) found a 43.6% cure rate among long-term survivors. Peritoneal mesothelioma is a rare form of one of the rarest cancers. Triggered almost exclusively by exposure to asbestos, mesothelioma affects about 2,500 Americans each year.  About a third of those patients are diagnosed with the peritoneal form of the disease, which occurs on the membrane that lines the abdomen and surrounds the internal organs. During cytoreductive surgery, surgeons attempt to remove all traces of the mesothelioma tumor so that no cells…

  • |

    New Prognostic Factor in Peritoneal Mesothelioma

    ByAlex Strauss

    Malignant peritoneal mesothelioma is a rare form of mesothelioma that attacks the membrane that lines the abdomen and surrounds internal organs. The outlook for this rare malignancy, which affects fewer than 500 Americans annually, has been improved by the treatment combination of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). The combination has produced 5-year overall survival rates ranging from 29% to 63%. But not all peritoneal mesothelioma patients are good candidates for CRS/HIPEC. The challenge, for clinicians, is identifying which patients are likely to benefit from the procedure (or even be cured) and which are not. In an effort to help answer that question, French researchers recently tested the prognostic value of the glucose transporter protein GLUT1 as well as…

  • |

    Study Lists Factors That Impact Mesothelioma Prognosis

    ByAlex Strauss

    Predicting survival in mesothelioma patients does not have to be complicated. A new Parisian study suggests that simple-to-measure factors such as patient age and the histological subtype of the mesothelioma can be highly accurate prognostic indicators. The study followed 170 patients diagnosed with malignant pleural mesothelioma between 2000 and 2010 at Saint Antoine Hospital in Paris. Patients in the study were all treated non-surgically. For each patient, a list of parameters was recorded including age, gender, tobacco use, asbestos exposure, type and duration of symptoms, BMI, C-reactive protein levels and white blood cell and platelet counts.  Inflammation of the pleura (pachypleuritis) was also noted, along with the type of diagnostic surgical procedure, histological subtype, the way in which pleurodesis was performed (for…

  • |

    Predicting Mesothelioma Outcomes with Blood Tests

    ByAlex Strauss

    Two separate teams of Japanese researchers are delving into the possibilities of blood serum indicators that could help predict outcomes in patients with malignant pleural mesothelioma. Mesothelioma is a rare but aggressive cancer caused by exposure to asbestos. Pleural mesothelioma, a cancer that starts on the lining around the lungs, is the most common form of the disease. It occurs most often in people who have inadvertently inhaled asbestos dust. Mesothelioma is highly resistant to conventional treatments. It is also difficult to predict which patients are likely to do well with standard therapies and which are not, which is referred to as prognosis. But researchers worldwide are continually searching for new ways to diagnose and predict the prognosis of patients with…